• Users Online: 245
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 


 
 Table of Contents  
LETTER TO EDITOR
Year : 2020  |  Volume : 12  |  Issue : 2  |  Page : 142

Maternal and fetal outcomes in patients with systemic lupus erythematosus - Authors' response


1 Department of Medicine, Faculty of Medicine, University of Benghazi, Benghazi, Libya
2 Department of Rheumatology, Aljamhorya Hospital, Benghazi, Libya

Date of Submission10-Jun-2020
Date of Acceptance11-Jun-2020
Date of Web Publication27-Jun-2020

Correspondence Address:
Dr. Khaled D Alsaeiti
Department of Rheumatology, Aljamhorya Hospital, Benghazi
Libya
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmbs.ijmbs_71_20

Rights and Permissions

How to cite this article:
Ahmed AM, Ibkhatra SA, Alsaeiti KD, Elbraky FM. Maternal and fetal outcomes in patients with systemic lupus erythematosus - Authors' response. Ibnosina J Med Biomed Sci 2020;12:142

How to cite this URL:
Ahmed AM, Ibkhatra SA, Alsaeiti KD, Elbraky FM. Maternal and fetal outcomes in patients with systemic lupus erythematosus - Authors' response. Ibnosina J Med Biomed Sci [serial online] 2020 [cited 2022 Aug 16];12:142. Available from: http://www.ijmbs.org/text.asp?2020/12/2/142/288207



Dear Editor,

We would like to thank Professor Mahmood Al-Mendalawi for his interest in the topic of our recent article.[1],[2] The study was a retrospective review of systemic lupus erythematosus (SLE) female patients who conceived during the period of January 2008–December 2018. Until then, classification of SLE was a yes-or-no decision, based on whether the patient had a minimum number of characteristic signs or symptoms. The new criteria, mentioned in the letter, were published in September 2019, by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) for the classification of SLE,[3] though the EULAR/ACR classification was reviewed deeply on 2017–2018.

Most of our rheumatologist still consider ACR criteria more applicable way to diagnose SLE. This is based on the fact that EULAR/ACR classification requires an antinuclear antibody titer of at least 1:80 on HEp-2 cells or an equivalent positive test at least once; otherwise, the patient is considered not to have SLE. This is not available in our area because of armed conflicts. Also, even if some labs offer the test, it would be expensive for most of patients. This point along with a longer list of weighted criteria ensures its utility in SLE research (including early or latent SLE), but not in clinical practice.

Authors' contributions

Equal.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Compliance with ethical principles

Inapplicable.



 
  References Top

1.
Ahmed AM, Ibkhatra SA, Elbraky FM, Alsaeiti KD. Maternal and fetal outcomes in patients with systemic lupus erythematosus. Ibnosina J Med Biomed Sci B 2020;12:33.  Back to cited text no. 1
    
2.
Al-Mendalawi M. Maternal and fetal outcomes in patients with systemic lupus erythematosus. Ibnosina J Med Biomed Sci B 2020;12:141.  Back to cited text no. 2
    
3.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019;71:1400-12.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed712    
    Printed43    
    Emailed0    
    PDF Downloaded73    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]